Researchers from the Howard Florey Institute, the University of Melbourne and the Mental Health Research Institute of Victoria, have devised a diagnostic test for Parkinson’s disease (PD), which would not only measure the levels of
'alpha-synuclein' protein in the blood, but also check the effect of candidate drugs in improving the level of the protein. If this blood test clears the clinical trials then there may be some hope in PD diagnosis to normalize the level of alpha-synuclein and bring many forms of PD to the forefront for efficient diagnosis.
Meanwhile, researchers at the Wellcome Trust Centre for Neuroimaging in London analyzed the effect of dopamine- related drugs on patients suffering from Parkinson’s disease (PD). The study included 39 healthy people, aged 18 to 39. Divided into three groups, they were administered levodopa, which increases dopamine levels in the brain, a dopamine receptor blocker called haloperidol (which decreases dopamine activity), and placebo respectively. Inference from the study was that dopamine drive leads people to compulsive behavior. The study is expected to look into the therapy that would control the effect of dopamine-related drugs, thereby controlling the compulsive behavior of PD victims.
A recent study on Parkinson’s disease (PD) claims to determine the impact of exercise in preventing the symptoms of PD. “The idea behind it is if we force them to pedal at a higher rate, this rate will allow them to have biochemical changes that are necessary for improvements in motor function. There's a possibility that there's an increase in dopamine, or there's a possibility that there's an increase in these neuro growth factors”, said Dr. Jay Albers of the Cleveland Clinic. Certain exercises like yoga, meditation improves the functioning of brain, and hence there are chances of exercise to ward-off the symptoms of PD in the primary phase.
Powered by Qumana